If you need more lookups,
subscriptions start at $34 USD/month.
Charles Beyrouthy Location
Cambridge, MA, US
Charles Beyrouthy Work
2022 -now Managing Partner and Founder @
2026 -now Investor @
2026 -now Investor @
2025 -now Investor @
2024 -now Investor @
2025 -now Member Board of Directors @
2023 -now Investor @
2023 -now Investor @
2023 -2025 Member of the Board of Advisors @
2025 -now Advisor @
2024 -now Member of the Board of Advisors @
2013 -now Co-Founder and Chairman of the Board @
Charles Beyrouthy Education
University of Massachusetts, Amherst
Bachelor of Science - BS
HBX | Harvard Business School
Certificate
GoingVC
Cohort 8
Charles Beyrouthy Skills
Venture Capital
Start-ups
R&D
Research
Strategy
Research and Development (R&D)
Biotechnology
Chemistry
Chemical Engineering
Molecular Biology
HPLC
Data Analysis
Nanotechnology
Cell Culture
Materials Science
Business Development
Life Sciences
Laboratory
Consulting
Statistics
High-Performance Liquid Chromatography (HPLC)
Lifesciences
Engineering
Laboratory Skills
PCR
Polymerase Chain Reaction (PCR)
Polymers
Spectroscopy
Organic Chemistry
Biochemistry
Microscopy
NMR
Management Consulting
Volunteer Organization
Protein Chemistry
Process Engineering
Engineering Consulting
Strategic Planning
Project Management
Business Strategy
Matlab
Mathematica
Microsoft Excel
Microsoft Office
Microsoft PowerPoint
Leadership
Management
Public Speaking
Polymer Engineering
Polymer Physics
Languages
Charles Beyrouthy Summary
Charles Beyrouthy, based in Cambridge, MA, US, is currently a Managing Partner and Founder at Forma Prime. Charles Beyrouthy brings experience from previous roles at Qunett, Stealth, Phantom Photonics and Metaphos. Charles Beyrouthy holds a Bachelor of Science - BS @ University of Massachusetts, Amherst. With a robust skill set that includes Venture Capital, Start-ups, R&D, Research, Strategy and more. Charles Beyrouthy has 1 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Charles Beyrouthy?
Find contact details for 700 million professionals.